Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies
Clinical trial NCT01724528 · COMPLETED
Trial details
- NCT number
- NCT01724528
- Sponsor
- Menarini Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-10-01
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.